ID   YU-1099
AC   CVCL_C8UM
SY   Yonsei University-1099
DR   Wikidata; Q123033988
RX   PubMed=31882684;
RX   PubMed=39874964;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Cys (c.2155G>T); ClinVar=VCV000016611; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser768Ile (c.2303G>T); ClinVar=VCV000045251; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
RX   PubMed=31882684; DOI=10.1038/s41598-019-56356-4; PMCID=PMC6934824;
RA   Kim S.-Y., Lee J.Y., Kim D.H., Joo H.-S., Yun M.R., Jung D., Yun J.,
RA   Heo S.G., Ahn B.-C., Park C.W., Pyo K.H., Chun Y.J., Hong M.H.,
RA   Kim H.R., Cho B.C.;
RT   "Patient-derived cells to guide targeted therapy for advanced lung
RT   adenocarcinoma.";
RL   Sci. Rep. 9:19909.1-19909.12(2019).
//
RX   PubMed=39874964; DOI=10.1016/j.xcrm.2025.101929;
RA   Oh S.Y., Park S., Lee S., Lee E.J., Kim T.H., Choi S.-J., Park S.Y.,
RA   Kim J.H., Lim S.M., Lee J.B., Cho B.C., Hong M.H., Yun M.R.;
RT   "The potential of lazertinib and amivantamab combination therapy as a
RT   treatment strategy for uncommon EGFR-mutated NSCLC.";
RL   Cell Rep. Med. 6:101929.1-101929.12(2025).
//